Your browser doesn't support javascript.
loading
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Dimopoulos, Meletios A; Gay, Francesca; Schjesvold, Fredrik; Beksac, Meral; Hajek, Roman; Weisel, Katja Christina; Goldschmidt, Hartmut; Maisnar, Vladimir; Moreau, Philippe; Min, Chang Ki; Pluta, Agnieszka; Chng, Wee-Joo; Kaiser, Martin; Zweegman, Sonja; Mateos, Maria-Victoria; Spencer, Andrew; Iida, Shinsuke; Morgan, Gareth; Suryanarayan, Kaveri; Teng, Zhaoyang; Skacel, Tomas; Palumbo, Antonio; Dash, Ajeeta B; Gupta, Neeraj; Labotka, Richard; Rajkumar, S Vincent.
Afiliação
  • Dimopoulos MA; Hematology & Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Electronic address: mdimop@med.uoa.gr.
  • Gay F; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria City of Health and Science of Turin, Turin, Italy.
  • Schjesvold F; Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.
  • Beksac M; Department of Hematology, Ankara University, Ankara, Turkey.
  • Hajek R; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Weisel KC; Department of Internal Medicine II, University of Tuebingen, Tuebingen, Germany.
  • Goldschmidt H; Department of Internal Medicine V, University Medical Hospital and National Center of Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Maisnar V; Fourth Department of Medicine-Hematology, FN and LF UK Hradec Králové, Hradec Králové, Czech Republic.
  • Moreau P; Department of Hematology, University Hospital Hôtel Dieu, University of Nantes, Nantes, France.
  • Min CK; Department of Internal Medicine, Seoul St Mary's Hospital, Seoul, South Korea.
  • Pluta A; Department of Haematology, Medical University of Lodz, Multidisciplinary Provincial Centre of Traumatology and Oncology Nicolas Copernicus in Lodz, Lodz, Poland.
  • Chng WJ; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore and Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Kaiser M; Department of Haematology, The Royal Marsden Hospital, London, UK; Division of Molecular Pathology, The Institute of Cancer Research ICR, London, UK.
  • Zweegman S; Department of Hematology, Amsterdam University Medical Center, VU University Amsterdam, Cancer Center Amsterdam, Netherlands.
  • Mateos MV; Department of Hematology, University Hospital of Salamanca, CIC, IBMCC, Salamanca, Spain.
  • Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VA, Australia.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Morgan G; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Suryanarayan K; Millennium Pharmaceuticals, Cambridge, MA, USA.
  • Teng Z; Millennium Pharmaceuticals, Cambridge, MA, USA.
  • Skacel T; Millennium Pharmaceuticals, Cambridge, MA, USA.
  • Palumbo A; Millennium Pharmaceuticals, Cambridge, MA, USA; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria S Giovanni Battista, Torino, Italy; Center for Hematology and Oncology, University Hospital Zürich, Zürich, Switzerland.
  • Dash AB; Millennium Pharmaceuticals, Cambridge, MA, USA.
  • Gupta N; Millennium Pharmaceuticals, Cambridge, MA, USA.
  • Labotka R; Millennium Pharmaceuticals, Cambridge, MA, USA.
  • Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Lancet ; 393(10168): 253-264, 2019 01 19.
Article em En | MEDLINE | ID: mdl-30545780
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Boro / Transplante de Células-Tronco / Glicina / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Boro / Transplante de Células-Tronco / Glicina / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido